Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients.

Ison MG, Llata E, Conover CS, Friedewald JJ, Gerber SI, Grigoryan A, Heneine W, Millis JM, Simon DM, Teo CG, Kuehnert MJ; HIV-HCV Transplantation Transmission Investigation Team..

Am J Transplant. 2011 Jun;11(6):1218-25. doi: 10.1111/j.1600-6143.2011.03597.x.

2.

The high-risk donor: viral infections in solid organ transplantation.

Singer AL, Kucirka LM, Namuyinga R, Hanrahan C, Subramanian AK, Segev DL.

Curr Opin Organ Transplant. 2008 Aug;13(4):400-4. doi: 10.1097/MOT.0b013e3283094ba3. Review.

PMID:
18685336
3.

Hepatitis C virus and nonliver solid organ transplantation.

Carbone M, Mutimer D, Neuberger J.

Transplantation. 2013 Mar 27;95(6):779-86. doi: 10.1097/TP.0b013e318273fec4. Review.

PMID:
23172130
4.

Transplantation of kidneys from HCV-positive donors: a safe strategy?

Fabrizi F, Bunnapradist S, Lunghi G, Martin P.

J Nephrol. 2003 Sep-Oct;16(5):617-25. Review.

PMID:
14733406
5.
6.
7.

HIV transmission by organ and tissue transplantation.

Simonds RJ.

AIDS. 1993 Nov;7 Suppl 2:S35-8. Review.

PMID:
8161444
8.
9.

Tissue donation and virus safety: more nucleic acid amplification testing is needed.

Pruss A, Caspari G, Krüger DH, Blümel J, Nübling CM, Gürtler L, Gerlich WH.

Transpl Infect Dis. 2010 Oct;12(5):375-86. doi: 10.1111/j.1399-3062.2010.00505.x. Review.

PMID:
20412535
10.

Infections in solid organ transplantation in special situations: HIV-infection and immigration.

Miró JM, Blanes M, Norman F, Martín-Dávila P.

Enferm Infecc Microbiol Clin. 2012 Mar;30 Suppl 2:76-85. doi: 10.1016/S0213-005X(12)70086-1. Review.

PMID:
22542039
11.

Infections transmitted from donors to recipients following organ transplantation.

Rao YG, Mirza DF.

Natl Med J India. 2005 Jul-Aug;18(4):189-94. Review.

PMID:
16252549
12.

Transplant tourism and donor-derived parasitic infections.

Kotton CN.

Transplant Proc. 2011 Jul-Aug;43(6):2448-9. doi: 10.1016/j.transproceed.2011.06.022. Review.

PMID:
21839290
13.
14.
15.

HTLV-1 in solid-organ transplantation: current challenges and future management strategies.

Armstrong MJ, Corbett C, Rowe IA, Taylor GP, Neuberger JM.

Transplantation. 2012 Dec 15;94(11):1075-84. doi: 10.1097/TP.0b013e318263ad7a. Review.

PMID:
23060278
16.

Renal transplantation from donors with a positive serology for hepatitis C.

Domínguez-Gil B, Esforzado N, Andrés A, Campistol JM, Morales JM.

Contrib Nephrol. 2012;176:117-29. doi: 10.1159/000332392. Review.

PMID:
22310787
17.

Reappraisal of the hepatitis C virus-positive donor in solid organ transplantation.

Patwardhan VR, Curry MP.

Curr Opin Organ Transplant. 2015 Jun;20(3):267-75. doi: 10.1097/MOT.0000000000000191. Review.

PMID:
25944236
18.

New technologies for infectious screening of organ donors.

Fishman JA.

Transplant Proc. 2011 Jul-Aug;43(6):2443-5. doi: 10.1016/j.transproceed.2011.06.019. Review.

PMID:
21839288
19.

Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.

Kucirka LM, Sarathy H, Govindan P, Wolf JH, Ellison TA, Hart LJ, Montgomery RA, Ros RL, Segev DL.

Am J Transplant. 2011 Jun;11(6):1188-200. doi: 10.1111/j.1600-6143.2011.03460.x. Review.

20.

Donor-derived infection--the challenge for transplant safety.

Fishman JA, Grossi PA.

Nat Rev Nephrol. 2014 Nov;10(11):663-72. doi: 10.1038/nrneph.2014.159. Review.

PMID:
25178971
Items per page

Supplemental Content

Support Center